NCT06026371

Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2023-12-12Est. Completion: 2026-09-30

Enrollment target: 157 participants

Locations

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt LymphomaNeuroblastomaEwing Sarcoma

Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab…

Los Angeles, United StatesEst. completion Mar 31, 2029

Sustained Monomorphic VT (MMVT)Recurrent Ventricular Tachycardia

This is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guide…

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.